Gene editing technology

We can produce blood cells reflecting various genetic backgrounds with genetic manipulation technology of progenitor cells.

Differentiation-inducing technology

We provide high-quality blood cells in a homogeneous differentiation
state from iPS cells with a high differentiation inducing rate.

Cell immortalization technology

We immortalize the cells just before each shipment. Thus, they maintain the original characteristics and can be used in experiments in a fresh condition.
Their characteristics are hard to change unlike originally
immortalized leukemia cell lines,
and you can obtain results similar to normal in vivo responses.

Consistent production technology

By improving the production efficiency, we can provide
the required number of blood cells stably at a reasonable price.